Company:  APYX MEDICAL CORP (APYX)
Form Type:  10-K
Filing Date:  3/14/2019 
CIK:  0000719135 
Address:  5115 ULMERTON ROAD 
City, State, Zip:  CLEARWATER, Florida 33760 
Telephone:  (727) 384-2323 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$7.22  
Change: 
0.21 (3.00%)  
Trade Time: 
Nov 11  
Market Cap: 
$244.91M
Trade APYX now with 

© 2019  
Description of Business
Apyx Medical Corporation ("Company", "Apyx Medical", "we", "us", or "our"), formerly known as Bovie Medical Corporation, was incorporated in 1982, under the laws of the State of Delaware and has its principal executive office at 5115 Ulmerton Road, Clearwater, FL 33760. We are a medical technology company and the developer of J-Plasma® (marketed and sold under the Renuvion(TM) Cosmetic Technology brand in the cosmetic surgery market), a patented plasma-based surgical product for cutting, coagulation and ablation of soft tissue. J-Plasma technology utilizes a helium ionization process to produce a stable, focused beam of plasma that provides surgeons with greater precision, and minimal invasiveness. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers.
Register and access this filing in:     
  FORM 10-K
    PART I
      ITEM 1. Business
      ITEM 1A. Risk factors
      ITEM 1B. Unresolved Staff Comments
      ITEM 2. Properties
      ITEM 3. Legal Proceedings
      ITEM 4. Mine Safety Disclosures
    PART II
      ITEM 5. Market for Registrant's Common Equity, Related ...
      ITEM 6. Selected Financial Data
      ITEM 7. Management's Discussion and Analysis of Financial ...
        Liquidity and Capital Resources
      ITEM 7A. Quantitative and Qualitative Disclosures about ...
      ITEM 8. Financial Statements and Supplementary Data
        REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
      ITEM 9. Changes in and Disagreements with Accountants on ...
      ITEM 9A. Controls and Procedures
      ITEM 9B. Other Information
    Part III
      ITEM 10. Directors, Executive Officers and Corporate Governance
        NAME AND TITLE
      ITEM 11. Executive Compensation Discussion and Analysis
        COMPENSATION TABLE
      ITEM 12. Security Ownership of Certain Beneficial Owners and ...
        BENEFICIAL OWNERS
      ITEM 13. Certain Relationships and Related Transactions and ...
      ITEM 14. Principal Accountant Fees and Services
    PART IV
    SIGNATURES
  EXHIBIT 10.10
  EXHIBIT 10.11
  EXHIBIT 22.1
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGISTERED
  EXHIBIT 31.1
  EXHIBIT 31.2
  EXHIBIT 32.1
    CERTIFICATION OF CEO
  EXHIBIT 32.2
    CERTIFICATION OF CFO